1. Assessment of CYP450 genetic variability effect on methadone dose and tolerance. (May 2014) Authors: Tsai, Hui-Ju; Wang, Sheng-Chang; Liu, Sheng-Wen; Ho, Ing-Kang; Chang, Yao-Sheng; Tsai, Yu-Ting; Lin, Keh-Ming; Liu, Yu-Li Journal: Pharmacogenomics Issue: Volume 15:Number 7(2014) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions. (July 2013) Authors: Kuo, Hsiang-Wei; Liu, Shu Chih; Tsou, Hsiao-Hui; Liu, Sheng-Wen; Lin, Keh-Ming; Lu, Shao-Chun; Hsiao, Mei-Chun; Hsiao, Chin-Fu; Liu, Chia-Yih; Chen, Chia-Hui; Lu, Mong-Liang; Shen, Winston W; Tang, Hwa-Sheng; Liu, Shen-Ing; Chang, Liang-Huey; Wu, Hsiao-Yu; Chang, Yao-Sheng; Yeh, Teng-Kuang; Chen,... Journal: Pharmacogenomics Issue: Volume 14:Number 10(2013) Page Start: 1191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗